Firefly Neuroscience (AIFF) Receivables - Other (2016 - 2025)

Firefly Neuroscience has reported Receivables - Other over the past 13 years, most recently at $184000.0 for Q3 2025.

  • Quarterly results put Receivables - Other at $184000.0 for Q3 2025, up 113.95% from a year ago — trailing twelve months through Sep 2025 was $184000.0 (up 113.95% YoY), and the annual figure for FY2024 was $121000.0, up 44.05%.
  • Receivables - Other for Q3 2025 was $184000.0 at Firefly Neuroscience, down from $197000.0 in the prior quarter.
  • Over the last five years, Receivables - Other for AIFF hit a ceiling of $342611.0 in Q1 2021 and a floor of $26026.0 in Q3 2023.
  • Median Receivables - Other over the past 5 years was $138391.5 (2022), compared with a mean of $144140.6.
  • Biggest five-year swings in Receivables - Other: surged 1854.3% in 2021 and later plummeted 86.14% in 2022.
  • Firefly Neuroscience's Receivables - Other stood at $186835.0 in 2021, then fell by 2.18% to $182756.0 in 2022, then crashed by 54.04% to $84000.0 in 2023, then surged by 44.05% to $121000.0 in 2024, then surged by 52.07% to $184000.0 in 2025.
  • The last three reported values for Receivables - Other were $184000.0 (Q3 2025), $197000.0 (Q2 2025), and $121000.0 (Q4 2024) per Business Quant data.